Read + Share

Amedeo Smart

Independent Medical Education


Read + Share

Eugenia-Toledo-Romani M, Verdecia-Sanchez L, Rodriguez-Gonzalez M, Rodriguez-Noda L, et al. Safety and immunogenicity of anti-SARS CoV-2 vaccine SOBERANA 02 in homologous or heterologous scheme: Open label phase I and phase IIa clinical trials. Vaccine 2022 Jun 6. pii: S0264-410X(22)00717.
PMID: 35691871


Privacy Policy